HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents.

*Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California; Division of Gastroenterology and Hepatology, University of Tennessee Health Science Center, Memphis, Tennessee; Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois; kSimmons Transplant Institute, Baylor All Saints Medical Center, Fort Worth, Texas; Depart...

متن کامل

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

The prevalence of patients with end-stage kidney disease (ESKD) on hemodialysis affected by hepatitis C virus (HCV) infection is 7.5% and many of these patients are on the waiting-list for kidney transplant [1]. Serum HCV positivity in kidney transplant recipients is significantly higher (around 10%) than in the general population, mostly due to the history of frequent blood transfusions, and i...

متن کامل

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

BACKGROUND & AIMS We determined the optimal HCV treatment prioritization strategy for interferon-free (IFN-free) HCV direct-acting antivirals (DAAs) by disease stage and risk status incorporating treatment of people who inject drugs (PWID). METHODS A dynamic HCV transmission and progression model compared the cost-effectiveness of treating patients early vs. delaying until cirrhosis for patie...

متن کامل

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

BACKGROUND HCV treatment uptake has drastically increased in HIV-HCV coinfected patients in France since direct-acting antiviral (DAA) treatment approval, resulting in HCV cure in 63% of all HIV-HCV patients by the end of 2015. We investigated the impact of scaling-up DAA on HCV prevalence in the whole HIV population and in various risk groups over the next 10 years in France using a transmissi...

متن کامل

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals

Therapy for human immunodeficiency virus (HIV) and chronic hepatitis C has evolved over the past decade, resulting in better control of infection and clinical outcomes; however, drug-drug interactions remain a significant hazard. Joint recommendations from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America regarding drug-drug interactions bet...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Frontiers in Medicine

سال: 2019

ISSN: 2296-858X

DOI: 10.3389/fmed.2019.00020